Citation tools
"BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair." Cancer Biology & Medicine
19.8
(2022):
1150-1171.
Web. 17 April. 2024.